References
- 1. AGGARWAL R, RINGOLD S, KHANNA D, NEOGI T, JOHNSON SR, MILLER A, et al. Distinctions between diagnostic and classification criteria? Arthritis care & research. 2015; 67(7):891-7.
- 2. LUIJTEN RK, FRITSCH-STORK RD, BIJLSMA JW, DERKSEN RH. The use of glucocorticoids in systemic lupus erythematosus. After 60 years still more an art than science. Autoimmunity reviews. 2013; 12(5):617-28.10.1016/j.autrev.2012.12.001
- 3. PETRI M, ORBAI AM, ALARCON GS, GORDON C, MERRILL JT, FORTIN PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis and rheumatism. 2012; 64(8):2677-86.
- 4. BARCELLINI W. Current treatment strategies in autoimmune hemolytic disorders. Expert review of hematology. 2015; 8(5):681-91.
- 5. ADAMS PC, BARTON JC. A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation. Journal of hepatology. 2011; 55(2):453-8.
- 6. KIM SE, KIM UJ, JANG MO, KANG SJ, JANG HC, JUNG SI, et al. Diagnostic use of serum ferritin levels to differentiate infectious and noninfectious diseases in patients with fever of unknown origin. Disease markers. 2013; 34(3):211-8.
- 7. GAVAND PE, SERIO I, ARNAUD L, COSTEDOAT-CHALUMEAU N, CARVELLI J, DOSSIER A, et al. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients. Autoimmunity reviews. 2017; 16(7):743-9.10.1016/j.autrev.2017.05.010
- 8. RIVIERE S, GALICIER L, COPPO P, MARZAC C, AUMONT C, LAMBOTTE O, et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. The American journal of medicine. 2014; 127(11):1118-25.
- 9. TAKAHASHI H, TSUBOI H, KURATA I, TAKAHASHI H, INOUE S, EBE H, et al. Predictors of the response to treatment in acute lupus hemophagocytic syndrome. Lupus. 2015; 24(7):659-68.
- 10. INGAWALE DK, MANDLIK SK, PATEL SS. An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance. Journal of complementary & integrative medicine. 2015; 12(1):1-13.
- 11. ZHANG B, SHI Y, LEI TC. Detection of active P-glycoprotein in systemic lupus erythematosus patients with poor disease control. Experimental and therapeutic medicine. 2012; 4(4):705-10.
- 12. DEJAGER L, VANDEVYVER S, PETTA I, LIBERT C. Dominance of the strongest: inflammatory cytokines versus glucocorticoids. Cytokine & growth factor reviews. 2014; 25(1):21-33.